Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy

INTRODUCTION: Personalized treatment for patients with membranous nephropathy requires accurate prediction of the disease course at an early stage. In this study, we evaluated the value of baseline anti–phospholipase A2 receptor (PLA2R1) antibody titer as a prognostic biomarker in patients with PLA2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int Rep
Main Authors: Logt, Anne-Els van de, Justino, Joana, Vink, Coralien H., van den Brand, Jan, Debiec, Hanna, Lambeau, Gérard, Wetzels, Jack F.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207302/
https://ncbi.nlm.nih.gov/pubmed/34169209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2021.04.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados